REPL

Replimune Group Inc (REPL)

US
$ 7.356.21%

Price Chart

Key Statistics

Market Cap
$ 615.73M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
753.25K
52W High
$ 17.00
52W Low
$ 4.92
Dividend Yield
0.00%
Beta
1.26

Technicals

50-Day MA
11.1015
200-Day MA
11.3018
52 Week High
17
52 Week Low
4.92

About REPL

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer.

Employees
331
Headquarters
Woburn, MA
CEO
Mr. Philip Astley-Sparke F.S.A.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg